115 related articles for article (PubMed ID: 6399880)
1. Quantification of large C3 fragments as an index of complement activation in mice. II. In vivo studies.
Lulé J; Fournié GJ; Conté JJ
Complement; 1984; 1(2):103-7. PubMed ID: 6399880
[TBL] [Abstract][Full Text] [Related]
2. Quantification of large C3 fragments as an index of complement activation in mice. I. In vitro studies.
Lulé J; Fournié GJ; Bousquet C; Dueymes JM; Pourrat JP; Conté JJ
Complement; 1984; 1(2):97-102. PubMed ID: 6544186
[TBL] [Abstract][Full Text] [Related]
3. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5.
Hodgetts SI; Grounds MD
Immunol Cell Biol; 2001 Jun; 79(3):231-9. PubMed ID: 11380675
[TBL] [Abstract][Full Text] [Related]
4. Complement-dependent B-cell activation by cobra venom factor and other mitogens?
Dukor P; Schumann G; Gisler RH; Dierich M; König W; Hadding U; Bitter-Suermann D
J Exp Med; 1974 Feb; 139(2):337-54. PubMed ID: 4589989
[TBL] [Abstract][Full Text] [Related]
5. Absence of a neutralizing antibody response to humanized cobra venom factor in mice.
Ing M; Hew BE; Fritzinger DC; Delignat S; Lacroix-Desmazes S; Vogel CW; Rayes J
Mol Immunol; 2018 May; 97():1-7. PubMed ID: 29525557
[TBL] [Abstract][Full Text] [Related]
6. Prolonged complement activation in mice.
Simpson IJ; Moran J; Evans DJ; Peters DK
Kidney Int; 1978 Jun; 13(6):467-71. PubMed ID: 713282
[TBL] [Abstract][Full Text] [Related]
7. The cobra complement system: I. The alternative pathway of activation.
Vogel CW; Müller-Eberhard HJ
Dev Comp Immunol; 1985; 9(2):311-25. PubMed ID: 3894085
[TBL] [Abstract][Full Text] [Related]
8. Modulation of mouse endotoxic fever by complement.
Li S; Holers VM; Boackle SA; Blatteis CM
Infect Immun; 2002 May; 70(5):2519-25. PubMed ID: 11953391
[TBL] [Abstract][Full Text] [Related]
9. Echinococcus granulosus: interactions with host complement in secondary infection in mice.
Díaz A; Ferreira AM; Nieto A
Exp Parasitol; 1995 May; 80(3):473-82. PubMed ID: 7729482
[TBL] [Abstract][Full Text] [Related]
10. Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum.
Edens RE; Linhardt RJ; Bell CS; Weiler JM
Immunopharmacology; 1994; 27(2):145-53. PubMed ID: 8014028
[TBL] [Abstract][Full Text] [Related]
11. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
Davis AE; Harrison RA; Lachmann PJ
J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
[TBL] [Abstract][Full Text] [Related]
12. Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure.
Cheung AK; Parker CJ; Wilcox L
Clin Exp Immunol; 1989 Nov; 78(2):299-306. PubMed ID: 12412765
[TBL] [Abstract][Full Text] [Related]
13. Complement component c5a is integral to the febrile response of mice to lipopolysaccharide.
Li S; Boackle SA; Holers VM; Lambris JD; Blatteis CM
Neuroimmunomodulation; 2005; 12(2):67-80. PubMed ID: 15785108
[TBL] [Abstract][Full Text] [Related]
14. In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje.
Van den Berg CW; Aerts PC; Van Dijk H
J Immunol Methods; 1991 Feb; 136(2):287-94. PubMed ID: 1999656
[TBL] [Abstract][Full Text] [Related]
15. Complement inactivation by recombinant human C3 derivatives.
Kölln J; Spillner E; Andrä J; Klensang K; Bredehorst R
J Immunol; 2004 Nov; 173(9):5540-5. PubMed ID: 15494503
[TBL] [Abstract][Full Text] [Related]
16. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
17. Complement C3 is required for the progression of cutaneous lesions and neutrophil attraction in Leishmania major infection.
Jacobs T; Andrä J; Gaworski I; Graefe S; Mellenthin K; Krömer M; Halter R; Borlak J; Clos J
Med Microbiol Immunol; 2005 May; 194(3):143-9. PubMed ID: 15378355
[TBL] [Abstract][Full Text] [Related]
18. Experimental studies on membranous nephropathy. (II) Role of complement system in proteinuria of passive Heymann nephritis.
Nishi T; Nosaka K; Kawasaki H
Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):301-7. PubMed ID: 6748340
[No Abstract] [Full Text] [Related]
19. Decomplementation with cobra venom factor prolongs survival of xenografted islets in a rat to mouse model.
Oberholzer J; Yu D; Triponez F; Cretin N; Andereggen E; Mentha G; White D; Buehler L; Morel P; Lou J
Immunology; 1999 May; 97(1):173-80. PubMed ID: 10447729
[TBL] [Abstract][Full Text] [Related]
20. Production of complement component C3 in vivo following 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure.
Lin WQ; White KL
J Toxicol Environ Health; 1993 Jun; 39(2):273-85. PubMed ID: 8501770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
